XCUR
Exicure, Inc.
$1.91
-0.07 (-3.54%)
At close · Jul 2
Going-concern doubt
— flagged May 29, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our ability to raise the additional capital that is needed to fund our operations and our pursuit of strategic alternatives, particularly given our current lack of a revenue source and the substantial doubt about our ability to continue as a going concern”View the 10-Q filed May 29, 2026
Market Cap
$12.17M
Shares
6,373,937
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.91
Open$1.96
Day$1.88–1.97
52W$1.71–9.50
Avg vol 30d36K
Short int15K · 0.2% float · 1.0d
Short vol0%
Last earningsMar 25, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 29
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Strong Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−54% below
−
Price vs 50-day avg
−35% below
◦
RSI (14)
30 · neutral
−
MACD trend
negative
−
52-week position
3% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $3 › 200d $4 — 200d above 50d
+
Institutional flow
+20% holders QoQ · +6 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.23% of float · ▼ -29.2% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
+
Institution breadth
18 holders — near 1-yr high, broad support
Fundamentals
Fair
−
Revenue growth
−100% Y/Y
+
EPS growth
+83% Y/Y
−
Free cash flow
$-8.6M
+
Balance sheet
net cash $5.6M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 3, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 29, 2026
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−54% below
Bearish
Price vs 50-day avg
−35% below
Bearish
RSI (14)
30 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
3% · near low
Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+20% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.23% of float · ▼ -29.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
18 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $2 · 3%
52-wk high $10
vs 200-day avg -54%
vs 50-day avg -35%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
XCUR
this stock
Exicure, Inc.
|
$12.17M | -64.8% | -100.0% | — | 0.2% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XCUR | -24.2% | -39.6% | -67.5% | -8.2% | -64.8% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -25.6% | -38.3% | -75.5% | -7.9% | -74.0% |